Influence of new societal factors on neovascular age-related macular degeneration outcomes

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2415
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Influence of new societal factors on neovascular age-related macular degeneration outcomes ; volume:18 ; number:1 ; day:1 ; month:2 ; year:2018 ; pages:1-8 ; date:12.2018
BMC ophthalmology ; 18, Heft 1 (1.2.2018), 1-8, 12.2018

Keyword
Augenheilkunde
Augenkrankheit

Creator
Giocanti-Aurégan, Audrey
Contributor
Chbat, Elige
Darugar, Adil
Morel, Christophe
Morin, Bruno
Conrath, John
Devin, François
SpringerLink (Online service)

DOI
10.1186/s12886-018-0690-9
URN
urn:nbn:de:1111-201803283728
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Giocanti-Aurégan, Audrey
  • Chbat, Elige
  • Darugar, Adil
  • Morel, Christophe
  • Morin, Bruno
  • Conrath, John
  • Devin, François
  • SpringerLink (Online service)

Other Objects (12)

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Near-infrared reflectance imaging of neovascular age-related macular degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Vision protection therapy for prevention of neovascular age-related macular degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Efficacy and safety of abicipar in neovascular age-related macular degeneration

Treatment of age-related neovascular macular degeneration: the patient’s perspective

Treatment of age-related neovascular macular degeneration: the patient’s perspective

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration

Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Characterization of two-pore channel 2 in neovascular age-related macular degeneration

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye

Related objects